Source: Focal Point Research Blog

Focal Point Research Blog Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19 (IO No. 2)

IO No. 2 repeals and replaces the Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19 (IO No. 1) made by the Minister on March 30, 2020 and approved by the Governor in Council (GIC) on April 8, 2020. It extends and modifies certain measures for drugs, [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Rob Fitchtner's photo - President & CEO of Focal Point Research

President & CEO

Rob Fitchtner

CEO Approval Rating

70/100